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The external iliac nodes lie near the external iliac vessels and are divided into lateral, middle, and medial subgroups based on their relationship to the external iliac artery and vein ( Figure 2 ). The lateral nodal subgroup, as expected, is located lateral to the external iliac artery. The middle subgroup is between the external iliac artery and vein. The medial subgroup is medial to the external iliac vessels and includes the subgroup of nodes near the obturator internus muscle and obturator vessels, sometimes called the obturator nodes. 1 Similar to the external iliac nodes, internal iliac nodes lie near the internal iliac vessels. There are four subgroups of the internal iliac nodes: lateral sacral, anterior sacral, anterior, and hypogastric. The lateral sacral nodes are near the paired lateral sacral arteries. The presacral nodes or anterior sacral nodes lie immediately anterior to the sacrum. The anterior nodes lie most anteriorly of the internal iliac nodes, at the origin of the anterior division of the internal iliac arteries ( Figure 3 ). The hypogastric nodes are the most cephalic of the internal iliac nodes. 1 The common iliac nodes are located more cephalic to the external and internal nodal stations, and they include the same three subgroups as with the external iliac lymph node station: lateral, medial, and middle subgroups. The lateral subgroup is lateral to the common iliac vessels. The medial subgroup is medial to the common iliac vessels. The middle subgroup is within the lumbosacral fossa, posterolateral to the common iliac vessels (Figure 4 ). 1 The para-aortic nodes lie near the aorta and inferior vena cava. 2 This nodal station is divided into seven subgroups, with four named by their relationship to the inferior vena cava, and the other three named by their relationship to the aorta ( Figure 5 ).
Perivisceral nodes describe those that are immediately adjacent to their respective pelvic viscera, such as periuterine or periprostatic. 
Prostate Cancer
Most commonly, prostate cancer spreads fi rst to the obturator nodes (i.e., medial subgroup of external iliac nodes) ( Figure 6 ) and then continues to the middle and lateral chains of the external iliac nodes. Less commonly, prostate cancer spreads fi rst to the internal iliac nodes. 1 In cancer affecting only one lobe of the prostate, spread is usually ipsilateral. 2 Prostate cancer most commonly spreads fi rst to the obturator nodes and then continues to the middle and lateral external iliac nodes.
In initial imaging of nodal metastases of prostate cancer for staging, the sensitivity of CT alone for detecting nodal involvement is around 40%. The utility of 18-fl uoro-2-deoxyglucose positron emission tomography/CT (18F-FDG-PET/ CT) is not well established, with sensitivities ranging from 0% to 50% and specifi cities ranging from 72% to 90%. 3 The wide range in sensitivities is likely due to small sample sizes and variability in the disease phase. 4 Detection of nodal involvement may be hindered by low FDG avidity of lowgrade prostate tumors and by excreted radiotracer within the adjacent urinary bladder. However, imaging with C11-acetate, which assesses lipogenesis and has minimal urinary excretion, demonstrates increased sensitivity for detection of prostate nodal metastasis. 4, 5 In the evaluation for nodal involvement of recurrent prostate cancer, 18F-FDG-PET/CT demonstrates a sensitivity Later, extension into the common iliac, internal iliac, and external iliac nodes typically is seen with tumor enlargement. Of note, after orchiectomy or other intervention, regional lymphatic drainage is altered, and recurrence may fi rst occur in the inguinal nodes. 1 Metastatic spread from testicular cancer most commonly involves ipsilateral para-aortic nodes; contralateral, without ipsilateral node metastases, is rare.
Sensitivity and specifi city of CT in staging testicular cancer are approximately 40% and 78%, respectively. With the addition of 18F-FDG-PET/CT, these estimates rise to approximately 70% and 100%, respectively (Figures 8 and 9 ). 5 18F-FDG-PET also may be useful after treatment of testicular cancer, as persistent nodal enlargement alone may not indicate presence of active disease. However, with the use of 18F-FDG-PET, differentiation among recurrent tumors and fi brosis or mature teratoma is possible with a sensitivity of 88%. 5
Penile and Vulvar Cancers
In both penile ( Figure 1 ) and vulvar carcinoma, metastasis most commonly occurs fi rst to the inguinal nodal groups. In both of these types of cancer, regional spread may occur to the bilateral inguinal nodes. When metastasis also occurs to other pelvic nodal groups, including internal iliac or external iliac nodes, this spread is considered regional metastatic disease for penile cancer. However, in vulvar cancer, spread to other pelvic nodal groups is classifi ed as distant metastatic disease. 1 The presence and extent of nodal involvement plays a large role in treatment and prognosis in each of these types of cancer. Therefore, the detection of involved lymph nodes is extremely important.
The sensitivity of CT alone in detecting metastatic disease in penile cancer is approximately 37%, which in several recent studies has been shown to increase to 80% to 88% using 18F-FDG-PET/CT. 3 In vulvar cancer, both CT alone and combined 18F-FDG-PET/CT provide low sensitivity for detection of nodal metastatic disease; however, 18F-FDG-PET/CT of 35% to 50%. 5 However, C11-acetate not only demonstrates increased sensitivity for nodal involvement of 80%, it also demonstrates a higher standard uptake value (SUV) compared with FDG. Although the use of C11-acetate in prostate cancer staging and evaluation for recurrent disease has promise, the 20-minute half-life limits its clinical utility.
Bladder Cancer
In general, obturator nodes are affected in 75% of patients in whom nodal metastases from bladder cancer are diagnosed. 1 The specifi c nodal pathway of spread depends on where the tumor is located in the bladder. Fundal tumors usually metastasize to the obturator and internal iliac nodes via an anterior drainage route (Figure 7) . Tumors in the lateral aspects of the bladder usually metastasize to the external iliac nodes, via lateral drainage. Bladder neck tumors usually metastasize via a presacral route to the presacral and common iliac nodes. 2 CT is 79% to 90% sensitive for initial staging of bladder metastatic nodal spread. 5 Imaging with 18F-FDG-PET/CT does not signifi cantly improve sensitivity for detection of regional nodal metastases because of urinary excretion of the radiotracer. However, 18F-FDG-PET/CT improves sensitivity for detection of distant lymph node involvement. 5 As with prostate cancer, imaging with C11-acetate, which is excreted predominantly through the liver, allows better visualization of disease in and around the bladder, and may have potential in imaging of bladder cancer.
Testicular Cancer
Metastatic spread of testicular cancer most commonly occurs through the ipsilateral para-aortic pathway, whereas contralateral spread without ipsilateral involvement is rare. The involved lymphatic chain is dependent on the portion of the endometrium involved; corpus lesions tend to metastasize to the external iliac nodes, particularly the obturator subgroup (Figure 2 ), whereas endometrial cancer with cervical extension tends to metastasize to the common iliac nodes as well as external iliac nodes.
Lymph node involvement of metastatic endometrial cancer is largely dependent on the depth of myometrial invasion of the tumor.
Using CT alone to evaluate initial nodal metastasis in endometrial cancer provides sensitivity of 18% to 66% and specifi city of 73% to 99%. 8 Using combined 18F-FDG-PET/CT for initial staging provides more sensitivity than CT alone, with sensitivity of 73% to 77%, but does not provide much improvement in specifi city (Figure 11 ). 8 Accuracy of nodal detection using 18F-FDG-PET/CT improves with increased nodal size, demonstrating only 17% sensitivity with 2-to 4-mm nodes, 67% sensitivity with 5-to 9-mm nodes, and greater than 90% sensitivity in 10-to 13-mm nodes. 8 In surveillance for nodal recurrence, 18F-FDG-PET/CT demonstrates sensitivity of 96% and specifi city of 78%, making it a promising option for imaging surveillance. 6 The 2011 ACR Appropriateness Criteria rank 18F-FDG-PET/CT as 9 for nodal evaluation of high-grade cancers that are FDG avid.
Cervical Cancer
Most commonly, cervical cancer spreads fi rst to the external iliac nodes, particularly the obturator subgroup. Less common sites of initial spread include the common or internal iliac nodes (Figure 3 ). Nodal spread after sentinel node metastasis is unpredictable and may be ipsilateral or contralateral to the sentinel node. Rarely does nodal spread involve the para-aortic nodes without pelvic node involvement. 1 has a high specifi city of 95%. Therefore, nodal tissue sampling still is performed frequently even in the presence of a negative 18F-FDG-PET/CT. 6 However, if a node is positive on 18F-FDG-PET/CT, the high specifi city makes it possible to avoid an unnecessary sentinel lymph node biopsy and progress directly to pelvic lymphadenectomy. 7 
Ovarian Cancer
Initial nodal spread of ovarian cancer may be quite heterogeneous. In most cases, the sentinel node is in the external iliac chain. However, it is not uncommon for initial spread to involve the common iliac, internal iliac, or even para-aortic chains. Bilateral involvement is frequent, and is seen in up to 50% of cases. 6 The nodal spread of ovarian cancer may be quite heterogeneous; however, in most cases, the sentinel node is in the external iliac chain.
In initial evaluation of nodal involvement for staging purposes, PET/CT does not show a clear benefi t over CT alone. False negatives may occur because of the cystic nature of many ovarian neoplasms or in a patient with a small or welldifferentiated tumor. False positives may occur because of concurrent infl ammatory processes. However, in evaluation for recurrent ovarian cancer, 18F-FDG-PET is a very useful adjunct to CT, with sensitivity and specifi city approaching 100% (Figures 4 and 10) . 6 The 2011 ACR Appropriateness criteria ranks 18F-FDG-PET/CT as 4 (of a possible 10) for initial ovarian staging but increases its utility to 8 for surveillance imaging.
Endometrial Cancer
Lymph node involvement of metastatic endometrial cancer is largely dependent on the depth of myometrial invasion of the tumor, with only a 3% rate of nodal involvement in superfi cial myometrial invasion, compared with 40% in deep myometrial invasion. 8 Both para-aortic and other pelvic lymph node involvement is considered regional nodal spread. Figure 8 shows lymph node (arrow) to be easily overlooked on routine cross-sectional imaging. Given its small size, the node would be indeterminate by CT size criteria for metastatic involvement. prognosis, with poorer prognosis being associated with both more distant nodal involvement and higher SUV of the affected nodes. 6 Based on the most recent ACR guidelines, 18F-FDG-PET/CT has an appropriateness rating for staging of cervical cancer of 8 to 9 depending on tumor size.
Conclusion
Evaluation of nodal metastatic disease is an essential component of both staging and surveillance of many malignancies. This CME activity emphasizes that in some instances, functional imaging with 18F-FDG-PET may be combined with anatomic CT images to improve accuracy in detection of nodal metastatic disease. Practicing radiologists need to be familiar with both the appropriate imaging modalities to assess for nodal metastatic disease and the characteristic locations and appearances of involved nodes. We have reviewed the anatomy of pelvic nodal pathways of spread of malignancies and detailed the common routes of spread of several common genitourinary male and female pelvic malignancies ( Table 2 on p. 8). Furthermore, we have reviewed the utility of 18F-FDG-PET/CT in assessing these primary pelvic malignancies for initial staging and surveillance.
Cervical cancer spreads most commonly fi rst to the external iliac nodes.
Aside from very small foci of disease, most cervical cancers show intense FDG avidity. Sensitivity of 18F-FDG-PET for initial staging of nodal metastases ranges from 75% to 100%, with a specifi city from 92% to 100%. This is superior to either CT or MRI in both sensitivity and specifi city. 6 False-negative results may relate to small size of tumor deposits and relatively poor spatial resolution of PET. False positives may be related to reactive lymph nodes or misattributing normal bowel or bladder activity to a nodal anatomic correlate.
18F-FDG-PET also is valuable in imaging for recurrent disease, with a sensitivity of 86% to 100% and a specifi city of 60% to 94%. Nodal status plays a major role in patient Figure 11 . A 45-year-old woman with invasive endometrial cancer arising in the uterine corpus. Contrast-enhanced CT scan from18F-FDG-PET/CT of the same patient as in Figure 2 shows right lateral external iliac lymph node (arrow) and a left medial external iliac lymph node (arrowhead) to be overlooked easily on routine cross-sectional imaging. Given their small size, these nodes would be indeterminate by CT size criteria for metastatic involvement. The nodes' intense FDG avidity on fused imaging strongly supports their malignant nature.
CME QUIZ: VOLUME 39, NUMBER 2
To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. Select the best answer and use a blue or black pen to completely fi ll in the corresponding box on the enclosed answer form. Please indicate any name and address changes directly on the answer form. If your name and address do not appear on the answer form, please print that information in the blank space at the top left of the page. Make a photocopy of the completed answer form for your own fi les and mail the original answer form in the enclosed postage-paid business reply envelope. Only two entries will be considered for credit. Your answer form must be received by Lippincott CME Institute, Inc., by January 14, 2017. At the end of each quarter, all CME participants will receive individual issue certifi cates for their CME participation in that quarter. These individual certifi cates will include your name, the publication title, the volume number, the issue number, the article title, your participation date, the AMA credit awarded, and any subcategory credit earned (if applicable). For more information, call (800) 638-3030. All CME credit earned via Contemporary Diagnostic Radiology will apply toward continuous certifi cation requirements. ABR continuous certifi cation requires 75 CME credits every 3 years, at least 25 of which must be self-assessment CME (SA-CME) credits. All SAM credits earned via Contemporary Diagnostic Radiology are now equivalent to SA-CME credits (www.theabr.org). Online quiz instructions: To take the quiz online, log on to your account at www.cdrnewsletter.com, and click on the "CME" tab at the top of the page. Then click on "Access the CME activity for this newsletter," which will take you to the log-in page for http://cme.lww.com. Enter your username and password. Follow the instructions on the site. You may print your offi cial certifi cate immediately. Please note: Lippincott CME Institute will not mail certifi cates to online participants. Online quizzes expire on the due date. All questions are ABR Self-Assessment Module (SAM) questions. Participants can claim credit for the SAM regardless of the test outcome. Notify the ABR of the SAM completion, or visit the ABR website at www.theabr.org to set up or log in to your personal database to record the number of SAMs you completed. Because CDR has been granted Deemed Status by the ABR, there will no longer be SAM ID numbers printed on the CME certifi cate. You may contact a MOC specialist at the ABR offi ce by calling 520-519-2152. Lateral to common iliac vessels Posterolateral to common iliac vessels Medial to common iliac vessels 5. Para-aortic Near aorta and inferior vena cava 6. Perivisceral
Immediately adjacent to their respective pelvic viscera 
